Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia, Refractory, With Excess of Blasts”

320 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 320 results

Very early researchEnded earlyNCT00361296
What this trial is testing

Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Ended earlyNCT00593554
What this trial is testing

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more
Sherif S. Farag 9
Early research (Phase 1)Study completedNCT02553941
What this trial is testing

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+2 more
Brian Jonas 21
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Testing effectiveness (Phase 2)Study completedNCT00357565
What this trial is testing

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesChildhood Acute Myeloid Leukemia in Remission+10 more
Masonic Cancer Center, University of Minnesota 34
Testing effectiveness (Phase 2)Study completedNCT00467961
What this trial is testing

Stem Cell Transplantation for Patients With Cancers of the Blood

Who this might be right for
CML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 61
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Large-scale testing (Phase 3)Study completedNCT00005866
What this trial is testing

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
SWOG Cancer Research Network 240
Early research (Phase 1)Looking for participantsNCT07321626
What this trial is testing

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Who this might be right for
Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more
First Affiliated Hospital of Zhejiang University 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04202835
What this trial is testing

ATG Plus PTCy vs ATG for CGVHD Prophylaxis

Who this might be right for
Acute LeukemiaMyelodysplasiaChronic Graft-versus-host-disease
McMaster University 80
Testing effectiveness (Phase 2)Study completedNCT01012492
What this trial is testing

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

Who this might be right for
AMLALLUndifferentiated Leukemia+9 more
Boston Children's Hospital 11
Early research (Phase 1)Study completedNCT00005064
What this trial is testing

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00054236
What this trial is testing

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00005622
What this trial is testing

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT03399773
What this trial is testing

Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
Fred Hutchinson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT03175978
What this trial is testing

IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicAnemia, Refractory, With Excess of Blasts
IGF Oncology, LLC 2
Not applicableStudy completedNCT00195533
What this trial is testing

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Who this might be right for
Hematological MalignancyLeukemiaMyelodysplasia+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 801
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976
What this trial is testing

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more
National Cancer Institute (NCI) 282
Early research (Phase 1)Study completedNCT00295971
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaLeukemiaMyelodysplastic Syndromes+1 more
University of California, San Francisco 21
Not applicableStudy completedNCT01956799
What this trial is testing

Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy

Who this might be right for
MyelodysplasiaMyelofibrosisAplastic Anemia
Fondazione Italiana Sindromi Mielodisplastiche-ETS 100
Load More Results